Access Vascular INC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$89Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
100clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Hydropicc Dual Lumen $43K associated (2023-2025)
- Vannas Capsulotomy Scissors $34K associated (2023-2025)
- Hydropicc Full Kit $34K associated (2023-2025)
- Hydromid Maximal Barrier Kit $34K associated (2023-2025)
- Vannas Deep Access Vascular Scissors $9,007 associated (2023-2025)
- Hydropicc $9,007 associated (2023-2025)
- Hydromid $9,007 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Michael Jaff | Boston, MA | Internal Medicine | $29,603.60 |
| Gary Ansel | Columbus, OH | Interventional Cardiology | $14,192.85 |
| David Longworth | Burlington, MA | Internal Medicine | $8,274.93 |
| Anand Patel | Winston Salem, NC | Diagnostic Radiology | $3,760.69 |
| Marcia Ryder | Syracuse, NY | Nurse Practitioner | $3,285.47 |
| Brian Jankowitz | Philadelphia, PA | Neurological Surgery | $2,887.50 |
| Matthew Ostroff | Paterson, NJ | Acute Care (Nurse Practitioner) | $2,696.49 |
| Keith Sterling | Springfield, VA | Vascular & Interventional Radiology | $2,518.65 |
| Arun Jagannathan | Kankakee, IL | Vascular & Interventional Radiology | $2,500.00 |
| Patrick Troy | Hartford, CT | Pulmonary Disease | $2,238.00 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.